메뉴 건너뛰기




Volumn 33, Issue 1, 2011, Pages 47-52

The effect of aspirin on C-reactive protein in hypertensive patients

Author keywords

aspirin; C reactive protein (CRP); hypertension

Indexed keywords

ACETYLSALICYLIC ACID; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; C REACTIVE PROTEIN; CALCIUM CHANNEL BLOCKING AGENT; CHOLESTEROL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

EID: 79251507701     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.3109/10641963.2010.503302     Document Type: Article
Times cited : (17)

References (44)
  • 1
    • 0030956673 scopus 로고    scopus 로고
    • Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
    • Ridker PM, Cushman M, Atampeer MJ, Tracy RP, Hennek-ens CH. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 1997;336: 973-979.
    • (1997) N Engl J Med , vol.336 , pp. 973-979
    • Ridker, P.M.1    Cushman, M.2    Atampeer, M.J.3    Tracy, R.P.4    Hennekens, C.H.5
  • 2
    • 0034704893 scopus 로고    scopus 로고
    • C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women
    • Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 2000; 342:836-843.
    • (2000) N Engl J Med , vol.342 , pp. 836-843
    • Ridker, P.M.1    Hennekens, C.H.2    Buring, J.E.3    Rifai, N.4
  • 3
    • 1642277853 scopus 로고    scopus 로고
    • Creactive pro-tein modulates risk prediction based on the Framingham score: Implications for future risk assessment: Results from a large cohort study in southern Germany
    • Koenig W, Löwel H, Baumert J, Meisinger C. Creactive pro-tein modulates risk prediction based on the Framingham score: implications for future risk assessment: results from a large cohort study in southern Germany. Circulation 2004;109: 1349-1353.
    • (2004) Circulation , vol.109 , pp. 1349-1353
    • Koenig, W.1    Löwel, H.2    Baumert, J.3    Meisinger, C.4
  • 4
    • 0030823183 scopus 로고    scopus 로고
    • IL-6 and APPs: Anti-inflamma-tory and immunosuppressive mediators
    • Tilg H, Dinarello CA, Mier J. IL-6 and APPs: anti-inflamma-tory and immunosuppressive mediators. Immunol Today 1997; 9:428-432.
    • (1997) Immunol Today , vol.9 , pp. 428-432
    • Tilg, H.1    Dinarello, C.A.2    Mier, J.3
  • 5
    • 28844475044 scopus 로고    scopus 로고
    • The novel role of Creactive protein in cardiovascular disease: Risk marker or pathogen
    • Wilson AM, Rhyan MC, Boyle AJ. The novel role of Creactive protein in cardiovascular disease: risk marker or pathogen. Int J Cardiol 2006;106:291-297.
    • (2006) Int J Cardiol , vol.106 , pp. 291-297
    • Wilson, A.M.1    Rhyan, M.C.2    Boyle, A.J.3
  • 6
    • 1842505521 scopus 로고    scopus 로고
    • Creactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases
    • Li JJ, Fang CH. Creactive protein is not only an inflammatory marker but also a direct cause of cardiovascular diseases. Med Hypotheses 2004;62:499-506.
    • (2004) Med Hypotheses , vol.62 , pp. 499-506
    • Li, J.J.1    Fang, C.H.2
  • 8
    • 0031454016 scopus 로고    scopus 로고
    • Prognostic influ-ence of increased fibrinogen and CRP levels in unstable coronary artery disease. Frisc Study Group. Fragmin during instability in coronary artery disease
    • Toss H, Lindahl B, Siegbahn A, Wallentin L. Prognostic influ-ence of increased fibrinogen and CRP levels in unstable coronary artery disease. Frisc Study Group. Fragmin during instability in coronary artery disease. Circulation 1997;96: 4204-4210.
    • (1997) Circulation , vol.96 , pp. 4204-4210
    • Toss, H.1    Lindahl, B.2    Siegbahn, A.3    Wallentin, L.4
  • 10
    • 0029810933 scopus 로고    scopus 로고
    • Relation to Creactive protein and coronary heart disease in the MRFIT nested case-control study
    • Kuller LH, Tracy RP, Shaten J, Meilahn EN. Relation to Creactive protein and coronary heart disease in the MRFIT nested case-control study. Am J Epidemiol 1996;144:537-547.
    • (1996) Am J Epidemiol , vol.144 , pp. 537-547
    • Kuller, L.H.1    Tracy, R.P.2    Shaten, J.3    Meilahn, E.N.4
  • 14
    • 34447637961 scopus 로고    scopus 로고
    • Comparison of a rapid platelet function assay-VerifyNow-Aspirin-with whole blood impedance aggregome-try for the detection of aspirin resistance
    • Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R. Comparison of a rapid platelet function assay-VerifyNow-Aspirin-with whole blood impedance aggregome-try for the detection of aspirin resistance. Thromb Res 2007; 120:485-488.
    • (2007) Thromb Res , vol.120 , pp. 485-488
    • Dyszkiewicz-Korpanty, A.M.1    Kim, A.2    Burner, J.D.3    Frenkel, E.P.4    Sarode, R.5
  • 15
    • 33644983315 scopus 로고    scopus 로고
    • Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome
    • Chen YG, Xu F, Zhang Y, Ji QS, Sun Y, Lu RJ, Li RJ. Effect of aspirin plus clopidogrel on inflammatory markers in patients with non-ST-segment elevation acute coronary syndrome. Chin Med J 2006;119:32-36.
    • (2006) Chin Med J , vol.119 , pp. 32-36
    • Chen, Y.G.1    Xu, F.2    Zhang, Y.3    Ji, Q.S.4    Sun, Y.5    Lu, R.J.6    Li, R.J.7
  • 16
    • 19944430180 scopus 로고    scopus 로고
    • A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and Creactive protein following myocardial infarction: The CADET trial
    • Woodward M, Lowe GD, Francis LM, Rumley A, Cobbe SM; CADET Study Investigators. A randomized comparison of the effects of aspirin and clopidogrel on thrombotic risk factors and Creactive protein following myocardial infarction: The CADET trial. J Thromb Haemost 2004;11:1934-1940.
    • (2004) J Thromb Haemost , vol.11 , pp. 1934-1940
    • Woodward, M.1    Lowe, G.D.2    Francis, L.M.3    Rumley, A.4    Cobbe, S.M.5
  • 18
  • 19
    • 33846856622 scopus 로고    scopus 로고
    • Creactive protein (CRP)-lowering agents
    • Prasad K. Creactive protein (CRP)-lowering agents. Cardiovasc Drug Rev 2006;24:33-50.
    • (2006) Cardiovasc Drug Rev , vol.24 , pp. 33-50
    • Prasad, K.1
  • 21
    • 0035875796 scopus 로고    scopus 로고
    • 2 concentrations: A placebo-controlled study using a highly sen-sitive Creactive protein assay
    • 2 concentrations: A placebo-controlled study using a highly sen-sitive Creactive protein assay. J Am Coll Cardiol 2001;37: 2036-2041.
    • (2001) J Am Coll Cardiol , vol.37 , pp. 2036-2041
    • Feldman, M.1    Jialal, I.2    Devaraj, S.3    Cryer, B.4
  • 23
    • 2442591457 scopus 로고    scopus 로고
    • Rofecoxib, a COX-2 inhibitor low-ers Creactive protein and interleukin-6 levels in patients with acute coronary syndromes
    • Monakier D, Mates M, Klutstein MW, Balkin JA, Rudensky B, Meerkin D, Tzivoni D. Rofecoxib, a COX-2 inhibitor low-ers Creactive protein and interleukin-6 levels in patients with acute coronary syndromes. Chest 2004;125:1610-1615.
    • (2004) Chest , vol.125 , pp. 1610-1615
    • Monakier, D.1    Mates, M.2    Klutstein, M.W.3    Balkin, J.A.4    Rudensky, B.5    Meerkin, D.6    Tzivoni, D.7
  • 24
    • 0037629751 scopus 로고    scopus 로고
    • Relationship between effects of statins, aspirin and angiotensin II modulators on high sensitive Creactive protein levels
    • Takeda T, Hoshida S, Nishino M, Tanouchi J, Otsu K, Hori M. Relationship between effects of statins, aspirin and angiotensin II modulators on high sensitive Creactive protein levels. Atherosclerosis 2003;169:155-158.
    • (2003) Atherosclerosis , vol.169 , pp. 155-158
    • Takeda, T.1    Hoshida, S.2    Nishino, M.3    Tanouchi, J.4    Otsu, K.5    Hori, M.6
  • 25
    • 0034669457 scopus 로고    scopus 로고
    • Cannon RO 3. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical manage-ment
    • Zanger D, Yang BK, Ardans J, Waclawiw MA, Csako G, Whli LM, Cannon RO 3. Divergent effects of hormone therapy on serum markers of inflammation in postmenopausal women with coronary artery disease on appropriate medical manage-ment. J Am Coll Cardiol 2000;36:1797-1802.
    • (2000) J Am Coll Cardiol , vol.36 , pp. 1797-1802
    • Zanger, D.1    Yang, B.K.2    Ardans, J.3    Waclawiw, M.A.4    Csako, G.5    Whli, L.M.6
  • 26
    • 31644451876 scopus 로고    scopus 로고
    • Lack of significant effect of low doses of aspirin on the concentrations of Creactive protein in a group of individuals with atherothrom-botic risk factors and vascular events
    • Rogowski O, Shapira I, Ben Assayang E, Bornstein NM, Tpker S, Melamed S, Shirom A, Berliner S. Lack of significant effect of low doses of aspirin on the concentrations of Creactive protein in a group of individuals with atherothrom-botic risk factors and vascular events. Blood Coagul Fibrinolysis 2006;17:19-22.
    • (2006) Blood Coagul Fibrinolysis , vol.17 , pp. 19-22
    • Rogowski, O.1    Shapira, I.2    Ben Assayang, E.3    Bornstein, N.M.4    Tpker, S.5    Melamed, S.6    Shirom, A.7    Berliner, S.8
  • 27
    • 31544464695 scopus 로고    scopus 로고
    • Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke
    • Zhao L, Gray L, Leonardi-Bee J, Weaver CS, Heptinstall S, Bath PM. Effect of aspirin, clopidogrel and dipyridamole on soluble markers of vascular function in normal volunteers and patients with prior ischaemic stroke. Platelets 2006;17: 100-104.
    • (2006) Platelets , vol.17 , pp. 100-104
    • Zhao, L.1    Gray, L.2    Leonardi-Bee, J.3    Weaver, C.S.4    Heptinstall, S.5    Bath, P.M.6
  • 28
    • 0025177196 scopus 로고
    • Elevation of Creactive protein in "active" coronary artery disease
    • Berk BC, Weintraub WS, Alexander RW. Elevation of Creactive protein in "active" coronary artery disease. Am J Cardiol 1990;65:168-172.
    • (1990) Am J Cardiol , vol.65 , pp. 168-172
    • Berk, B.C.1    Weintraub, W.S.2    Alexander, R.W.3
  • 31
    • 0035963529 scopus 로고    scopus 로고
    • Air force/Texas coronary atherosclerosis pre-vention study investigators. Measurement of Creactive pro-tein for the targeting of statin therapy in the primary prevention of acute coronary events
    • Ridker PM, Rifai, N, Clearfield M, Downs JR, Weis SE, Miles JS, Gotto AM Jr. Air force/Texas coronary atherosclerosis pre-vention study investigators. Measurement of Creactive pro-tein for the targeting of statin therapy in the primary prevention of acute coronary events. N Engl J Med 2001;344: 1959-1965.
    • (2001) N Engl J Med , vol.344 , pp. 1959-1965
    • Ridker, P.M.1    Rifai, N.2    Clearfield, M.3    Downs, J.R.4    Weis, S.E.5    Miles, J.S.6    Gotto Jr., A.M.7
  • 35
    • 0035806626 scopus 로고    scopus 로고
    • Effect of statin therapy on Creactive protein levels: The Pravastatin Inflammation/CRP Evaluation (PRINCE), a randomized trial and cohort study
    • Albert MA, Danielson E, Rifai N, Ridker PM. Effect of statin therapy on Creactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE), a randomized trial and cohort study. J Am Med Assoc 2001;286:64-70.
    • (2001) J Am Med Assoc , vol.286 , pp. 64-70
    • Albert, M.A.1    Danielson, E.2    Rifai, N.3    Ridker, P.M.4
  • 37
    • 0037212882 scopus 로고    scopus 로고
    • Strong decrease of high sensitivity Creactive protein with high-dose atorvastatin in patients with type-2 diabetes mellitus
    • DALI-study Group
    • Van de Ree MA, Huisman MV, Princen HM, Meinders AE, Kluft C; DALI-study Group. Strong decrease of high sensitivity Creactive protein with high-dose atorvastatin in patients with type-2 diabetes mellitus. Atherosclerosis 2003;166:129-135.
    • (2003) Atherosclerosis , vol.166 , pp. 129-135
    • Van De Ree, M.A.1    Huisman, M.V.2    Princen, H.M.3    Meinders, A.E.4    Kluft, C.5
  • 38
    • 28444451901 scopus 로고    scopus 로고
    • Atorvastatin lowers plasma low-density lipo-protein cholesterol and Creactive protein in Japanese type 2 diabetic patients
    • Yamada S, Yanagawa T, Sasamoto K, Araki A, Miyao M, Yamanouchi T. Atorvastatin lowers plasma low-density lipo-protein cholesterol and Creactive protein in Japanese type 2 diabetic patients. Metabolism 2006;55:67-71.
    • (2006) Metabolism , vol.55 , pp. 67-71
    • Yamada, S.1    Yanagawa, T.2    Sasamoto, K.3    Araki, A.4    Miyao, M.5    Yamanouchi, T.6
  • 40
    • 20044367345 scopus 로고    scopus 로고
    • Aggressive antihypertensive therapy based on hydrochlorothi-azide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: Effects on albumin excretion, endothelial function and inflammation in double-blind, ran-domized clinical trial
    • Schram MT, van Ittersum FJ, Spoelstra-de Man A, van Dijk RA, Schalkwijk CG, Ijzerman RG, Twisk JW, Stehouwer CD. Aggressive antihypertensive therapy based on hydrochlorothi-azide, candesartan or lisinopril as initial choice in hypertensive type II diabetic individuals: Effects on albumin excretion, endothelial function and inflammation in double-blind, ran-domized clinical trial. J Hum Hypertens 2005;19:429-437.
    • (2005) J Hum Hypertens , vol.19 , pp. 429-437
    • Schram, M.T.1    Van Ittersum, F.J.2    Spoelstra-De Man, A.3    Van Dijk, R.A.4    Schalkwijk, C.G.5    Ijzerman, R.G.6    Twisk, J.W.7    Stehouwer, C.D.8
  • 42
    • 2542475889 scopus 로고    scopus 로고
    • Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy
    • Yasunari K, Maeda K, Watanabe T, Nakamura M, Yoshikawa J, Asada A. Comparative effects of valsartan versus amlodipine on left ventricular mass and reactive oxygen species formation by monocytes in hypertensive patients with left ventricular hypertrophy. J Am Coll Cardiol 2004;43:2116-2123.
    • (2004) J Am Coll Cardiol , vol.43 , pp. 2116-2123
    • Yasunari, K.1    Maeda, K.2    Watanabe, T.3    Nakamura, M.4    Yoshikawa, J.5    Asada, A.6
  • 44
    • 18244384044 scopus 로고    scopus 로고
    • Carvedilol reduces plasma 8-hydroxy-2-deoxygua-nosine in mild to moderate hypertension: A pilot study
    • Lee J, Lee M, Kim JU, Song KI, Choi YS, Cheong SS. Carvedilol reduces plasma 8-hydroxy-2-deoxygua-nosine in mild to moderate hypertension: A pilot study. Hypertension 2005;45:986-990.
    • (2005) Hypertension , vol.45 , pp. 986-990
    • Lee, J.1    Lee, M.2    Kim, J.U.3    Song, K.I.4    Choi, Y.S.5    Cheong, S.S.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.